Total Funding
3
Total FundingSeries B raised
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Virobay develops small molecule, antiviral drug treatments for autoimmune diseases, neuropathic pain, liver diseases, and cancer.
David B. Karpf: Vice President and Chief Medical Officer- Heather Preston: Co-Founder & CEOPast Role: TPG Biotech, Partner and Managing Director
About the Company
Virobay, Inc. operates as an anti-viral drug discovery and development company. It engages in developing, investigating, and creating treatments for hepatitis C, such as protease and polymerase inhibitors. The company was founded in 2006 and is headquartered in Menlo Park, California.
Women Founded
Women Led
